I-Mab Biopharma
IMAB
#9318
Rank
โ‚ฌ57.99 M
Marketcap
0,71ย โ‚ฌ
Share price
-5.65%
Change (1 day)
-57.67%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -โ‚ฌ0.19 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are โ‚ฌ3.27 Million. a decrease over its 2023 earnings that were of -โ‚ฌ5.94 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ44.04 Million642.25%
2023 -โ‚ฌ5.94 Million-11.48%
2022-โ‚ฌ6.71 Million-86.72%
2021-โ‚ฌ50.47 Million-605.96%
2020 โ‚ฌ9.97 M-138.32%
2019 -โ‚ฌ26.03 Million260.14%
2018 -โ‚ฌ7.23 Million19.49%
2017-โ‚ฌ6.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ15.95 Million-90.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ9.1 Million-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA